I want to thank the many people who responded to last week's posting** on talking publicly about being diabetic (lots of emails). It is heartening to know that most of you are quite open about your diabetes, at least in your personal lives. (Although I need to keep my eyes peeled in public restrooms —- our No.1 refuge, it seems.)
A number of people were skeptical about "talking" at work, and suggested a "need-to-know" policy to avoid any branding. A few people said it was important to tell your boss, for sure, but not until you're through interviewing and well established in the job (!)
I even got some sympathy for my "not wanting to DEAL with it" issue: one apparently well-adjusted fellow Type 1 writes: "I completely understand what you mean ... so many people know so little about diabetes, and what they do 'know' is about their 77 year old aunt with Type 2." Precisely!
* * *
A quick note of reaction to the new dLife TV show: most of us seem to agree it was boring, and clearly "a drug company/equipment sales pitch from start to finish," as The Diabetes Blog reader Lance Lavery points out. Disappointed!
(**Publisher's Note: My March 13 posting "Out of the Closet, or NOT" has also been reprinted with permission on the DiabetesMonitor.com.)
While we're on a roll updating you all about the activities of various advocacy orgs, here's another one we're excited about: the national women's diabetes group DiabetesSisters is launching a new project to open a direct line of communication bet...
With the 10th annual Rare Disease Day just around the corner on Feb. 28, it's a perfect time to revisit the issue of "brittle diabetes" and how recognition of it as a rare disease (or lack thereof) has sparked a new wave of controversy recently. ...
Welcome back to our weekly diabetes advice column, Ask D'Mine - with your host veteran type 1, and diabetes author Wil Dubois. On this President's Day weekend, Wil is helping a reader trump his fears about the state of healthcare coverage in the U...
You may have heard that the battle over insulin access and affordability has made its way into court, challenging status quo drug-pricing methods and actually accusing the three Big Insulin makers of illegal price-gouging that endangers people wit...
February is of course awards season thanks to the Grammys and Oscars, and in keeping with tradition we're excited to once again offer our own take on the "best-of" in various categories among the Diabetes Community. What's unique about our Dia...